R&D

At GE Healthcare, we strive to see life more clearly. Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing healthcare costs, increasing access and improving quality and efficiency around the world.

The National Institute of Pharmaceutical Education and Research has been established under the aegis of Ministry of Chemicals and Fertilizers, Government of India, Dept. of Pharmaceuticals as a Centre of Excellence in imparting higher education, research and development in pharmaceutical sciences and is the first Institute of its kind in country. The Institute was declared as an Institute of National Importance by Government of India through an Act of Parliament, notified on 26th June 1998.

The ICGEB is an international, nonprofit research organization. Established as a special project of UNIDO, it became fully autonomous in 1994 and now counts over 60 Member States. The International Centre for Genetic Engineering and Biotechnology provides a scientific and educational environment of the highest standard and conducts innovative research in life sciences for the benefit of developing countries.

Monsanto India Limited (MIL) - a subsidiary of the Monsanto Company, USA - is the only publicly listed Monsanto entity outside USA.  With a presence of more than six decades in India, MIL is committed to help the Indian farmer produce more while conserving sustainably and to be successful. MIL focuses on maize (Dekalb®, India's largest selling hybrid maize seed brand) and agricultural productivity (Roundup®, the world, as well as India's largest selling glyphosate herbicide).

Indian Institute of Chemical Technology, Hyderabad is a premier R&D Institute in India. The Institute had its origin as the Central Laboratories for Scientific & Industrial Research (CLSIR), established in 1944 by the then Government of Hyderabad State. After integration of Hyderabad State with the Indian Union, the laboratory expanded with its growing activities. The main building was formally opened by Pandit Jawaharlal Nehru, the then Prime Minister of India on January 2, 1954.

The Centre for DNA Fingerprinting and Diagnostics (CDFD) is an autonomous organization funded by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. CDFD receives funding also from other agencies on specific collaborative projects.

Piramal Life Sciences Limited (PLSL) is an independent research-driven drug company that was recently demerged from Piramal Healthcare Limited (Formerly known as Nicholas Piramal India Limited). PLSL was formerly the NCE R&D division of NPIL. PLSL has state-of-the-art R&D laboratories built over 200,000 square-feet of space in Mumbai, India and over 300 scientists engaged in drug discovery and development.